We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$120B
AUM Growth
+$2.68B
Cap. Flow
-$4.47B
Cap. Flow %
-3.72%
Top 10 Hldgs %
12.85%
Holding
2,691
New
107
Increased
717
Reduced
1,008
Closed
96

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$505M
2
VRSN icon
VeriSign
VRSN
+$382M
3
BAX icon
Baxter International
BAX
+$374M
4
ADI icon
Analog Devices
ADI
+$219M
5
CHWY icon
Chewy
CHWY
+$206M

Sector Composition

Rank Sector Weight
1 Technology 25.17%
2 Healthcare 14.7%
3 Financials 13.17%
4 Industrials 10.74%
5 Consumer Discretionary 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HR icon
926
Healthcare Realty
HR
$7.46B
$10.3M 0.01%
311,621
-6,983
-2% -$233K
MRTX
927
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$10.2M 0.01%
69,810
+212
+0.3% +$32.9K
WU icon
928
Western Union
WU
$2.55B
$10.2M 0.01%
573,328
+69,635
+14% +$1.28M
NMRK icon
929
Newmark Group
NMRK
$2.82B
$10.1M 0.01%
540,763
-23,163
-4% -$369K
FHN icon
930
First Horizon
FHN
$12.1B
$10.1M 0.01%
618,874
+96,039
+18% +$1.6M
ENPH icon
931
Enphase Energy
ENPH
$5.01B
$10.1M 0.01%
54,989
-67,108
-55% -$14M
ICPT
932
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.1M 0.01%
617,497
-3,915
-0.6% -$66K
VRNT
933
DELISTED
Verint Systems
VRNT
$10M 0.01%
190,630
+2,889
+2% +$139K
ALKS icon
934
Alkermes
ALKS
$8.79B
$9.94M 0.01%
427,427
TROW icon
935
T. Rowe Price
TROW
$25.5B
$9.91M 0.01%
50,419
+11,688
+30% +$2.37M
OPLN
936
Openlane
OPLN
$4.25B
$9.91M 0.01%
634,498
+14,158
+2% +$217K
LICY
937
DELISTED
Li-Cycle Holdings Corp.
LICY
$9.87M 0.01%
123,881
+110,573
+831% +$10.4M
AAQC
938
DELISTED
Accelerate Acquisition Corp
AAQC
$9.72M 0.01%
1,000,000
SOVO
939
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$9.7M 0.01%
644,350
+294,098
+84% +$4.38M
RMD icon
940
ResMed
RMD
$29.5B
$9.62M 0.01%
36,938
-18,435
-33% -$4.78M
XLNX
941
DELISTED
Xilinx Inc
XLNX
$9.56M 0.01%
45,089
-17,419
-28% -$3.44M
LFUS icon
942
Littelfuse
LFUS
$10.2B
$9.54M 0.01%
30,323
+9,180
+43% +$2.78M
DT icon
943
Dynatrace
DT
$12.7B
$9.54M 0.01%
158,032
+22,266
+16% +$1.52M
VTWO icon
944
Vanguard Russell 2000 ETF
VTWO
$17.4B
$9.53M 0.01%
106,127
HLF icon
945
Herbalife
HLF
$1.26B
$9.5M 0.01%
232,032
VOO icon
946
Vanguard S&P 500 ETF
VOO
$968B
$9.46M 0.01%
21,670
+14,690
+210% +$6.2M
WBA
947
DELISTED
Walgreens Boots Alliance
WBA
$9.38M 0.01%
179,836
+100,293
+126% +$4.86M
INCY icon
948
Incyte
INCY
$23.7B
$9.38M 0.01%
127,738
-23,407
-15% -$1.58M
BKLN icon
949
Invesco Senior Loan ETF
BKLN
$6.97B
$9.37M 0.01%
424,157
STOR
950
DELISTED
STORE Capital Corporation
STOR
$9.36M 0.01%
274,694
+2,071
+0.8% +$70.3K

Similar funds

Macquarie Group's Q4 2021 Portfolio in Review

As of Q4 2021, Macquarie Group held 2,691 positions worth $120B, up 2.3% from $117B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Macquarie Group withdrew a net $4.47B in Q4 2021, closing 96 positions and reducing 1,008 holdings. Its most notable exit was SK Telecom, an estimated $256M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in GlobalFoundries worth $182M.

  • Macquarie Group's largest Q4 2021 buy was GlobalFoundries: 2,804,906 shares worth $182M.
  • Macquarie Group added most to TJX Companies in Q4 2021, an estimated $505M increase.
  • Macquarie Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $733M.
  • Macquarie Group fully exited SK Telecom in Q4 2021, selling an estimated $256M.
  • Macquarie Group's ten largest holdings make up 13% of its $120B portfolio in Q4 2021.
  • Macquarie Group opened 107 new positions and closed 96 in Q4 2021.
  • Macquarie Group's portfolio value rose 2.3% quarter-over-quarter to $120B.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.